Next Generation News and Research

RSS

Second Edition of Human Evolutionary Genetics now available

Garland Science is proud to announce the publication of the long-awaited Second Edition of Human Evolutionary Genetics by Jobling, Hollux, Hurles, Kivisild, and Tyler-Smith.

27 Jun 2013

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys AG and Celgene Corporation today announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

27 Jun 2013

New streamlined method harnesses tumor-infiltrating lymphocytes to improve outcomes

Jamie K. Teer, Ph.D., assistant member of the Cancer Biology and Evolution Program at Moffitt Cancer Center, and colleagues have developed a new streamlined method to rapidly identify the genetic changes in small protein fragments unique to melanoma cancer cells.

26 Jun 2013

Advaxis seeks ADXS-HPV Orphan Drug Designation for treatment of HPV-associated anal cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.

25 Jun 2013

Wayne State University awards $1.8 million for development of multidisciplinary research groups

Wayne State University's Office of the Vice President for Research today announced two research awards totaling $1.8 million in the Multidisciplinary Research Group Incubator Program (MRGIP), an internal funding program at the university.

21 Jun 2013

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.

21 Jun 2013

Researchers identify new virus in patients with severe brain infections

Researchers have identified a new virus in patients with severe brain infections in Vietnam. Further research is needed to determine whether the virus is responsible for the symptoms of disease.

18 Jun 2013

New technique offers potential to screen patients for viruses

In research published in Biochemical and Biophysical Research Communications, Saint Louis University researchers describe a technology that can detect new, previously unknown viruses. The technique offers the potential to screen patients for viruses even when doctors have not identified a particular virus as the likely source of an infection.

18 Jun 2013

New CREHST program aims to expose students to clinical aspect of cancer research

Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.

18 Jun 2013

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab A/S and ADC Therapeutics Sarl, announced today an agreement to develop a new antibody-drug conjugate product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.

17 Jun 2013

Biozoom exercises option to acquire 19.9% of Opsolution

Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.

15 Jun 2013

HandsFree system helps analyze next generation sequencing data

In the early 1990s, an international effort was launched by the U.S. Department of Energy and the National Institutes of Health to sequence the human genome. The project took 13 years, involved many scientists in several countries, and cost $2.7 billion (in FY 1991) dollars.

15 Jun 2013

Ambry Genetics introduces BRCA1 and BRCA2 analysis

Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.

14 Jun 2013

Pathway Genomics announces launch of inherited cancer panel with BRCA1 and BRCA2

Pathway Genomics, a genetic testing laboratory on the forefront of bringing physicians a broad genetic testing portfolio covering a wide range of diseases, announces the pending launch of its inherited cancer panel with BRCA1 and BRCA2.

14 Jun 2013

Clear Lake Regional Medical Center opens new tower to better serve Bay Area Houston community

Clear Lake Regional Medical Center today celebrated the grand opening of its $92 million expansion project that will enhance services to better serve the Bay Area Houston community.

14 Jun 2013

Next-generation self-expanding clot removal device from Codman Neuro obtains CE mark

Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke, the company announced today at the Live Interventional Neuroradiology & Neurosurgery Course (LINNC) in Paris.

13 Jun 2013

SV Bio receives CLIA certification for in silico diagnostics laboratory

Silicon Valley Biosystems today announced that it has received Clinical Laboratory Improvement Amendment certification from the California Department of Public Health for its in silico diagnostics laboratory.

13 Jun 2013

Study: Stress felt by dad leaves lasting impression on his sperm

Sperm doesn't appear to forget anything. Stress felt by dad-whether as a preadolescent or adult-leaves a lasting impression on his sperm that gives sons and daughters a blunted reaction to stress, a response linked to several mental disorders.

13 Jun 2013

New collaboration to advance cancer immunotherapy research

The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design, a biotech company focused on immune-based therapies for cancer and other human diseases, today announced that they have signed a collaboration agreement to advance cancer immunotherapy research.

13 Jun 2013

RTI Biologics intents to acquire privately held Pioneer Surgical Technology

RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich.

12 Jun 2013

Next Generation News and Research

Second Edition of Human Evolutionary Genetics now available

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

New streamlined method harnesses tumor-infiltrating lymphocytes to improve outcomes

Advaxis seeks ADXS-HPV Orphan Drug Designation for treatment of HPV-associated anal cancer

Wayne State University awards $1.8 million for development of multidisciplinary research groups

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Researchers identify new virus in patients with severe brain infections

New technique offers potential to screen patients for viruses

New CREHST program aims to expose students to clinical aspect of cancer research

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Biozoom exercises option to acquire 19.9% of Opsolution

HandsFree system helps analyze next generation sequencing data

Ambry Genetics introduces BRCA1 and BRCA2 analysis

Pathway Genomics announces launch of inherited cancer panel with BRCA1 and BRCA2

Clear Lake Regional Medical Center opens new tower to better serve Bay Area Houston community

Next-generation self-expanding clot removal device from Codman Neuro obtains CE mark

SV Bio receives CLIA certification for in silico diagnostics laboratory

Study: Stress felt by dad leaves lasting impression on his sperm

New collaboration to advance cancer immunotherapy research

RTI Biologics intents to acquire privately held Pioneer Surgical Technology

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News